Screener
Clover Health Investments CLOV Q2 2026 earnings
Reported August 5, 2026 · After market close
Revenue$743.2MBeat by $14.9M
EPS$0.05Beat by $0.01
Revenue estimate$728.3M
EPS estimate$0.04
“Our results demonstrate that a wide-network, full-risk Medicare Advantage model can deliver better health outcomes, meaningful growth, and increasing profitability at the same time”
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$740.3M
EPS estimate-$0.01
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Clover Health Investments report Q2 2026 earnings?
- Clover Health Investments (CLOV) reported Q2 2026 earnings on August 5, 2026 after market close.
- What were Clover Health Investments's Q2 2026 revenue and EPS?
- Clover Health Investments reported revenue of $743.2M and eps of $0.05 for Q2 2026.
- Did Clover Health Investments beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $728.3M by $14.9M. EPS beat the consensus estimate of $0.04 by $0.01.
- How did Clover Health Investments's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 55.6% from $477.6M a year earlier and eps grew 66.7% from $0.03.
- Where can I find Clover Health Investments's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001801170-26-000196) and the 10-Q periodic report (0001801170-26-000200) directly on SEC EDGAR. The filing index links above go to sec.gov.
